FOS and cancer: It is reported that suppression of RSK2 function inhibited AP-1 transactivation activity [27], and AP-1 is a well-known transcription factor that facilitates the progression of various cancers and mediates cell transformation [28]; therefore, we hypothesized that CD147 might regulate AP-1 activity.